Global News and Digital Insights
for the Healthcare Industry

Day: May 9, 2022

Orion joins hands with Jemincare to formulate non-opioid drug for chronic pain

HealthGeniuses May 9, 2022

Jemincare, with the help of Orion, will be furthering the development of their non-opioid drug JMKX000623, an inhibitor of a main sodium channel subtype that balances out pain fibres’ stimulation. Orion corporation has partnered up with Jemincare where the former will be responsible for the international development and marketing rights of the non-opioid drug. This drug will treat acute as well as chronic pain. In addition to royalty payments, Orion will also make an upfront payment of $15 million to Jemincare. Read More from Pharmaceutical Technology 

Albertsons Companies is focusing on the concept of ‘food as medicine’ for shoppers

HealthGeniuses May 9, 2022

One of the leading food and medicine retailers, Albertsons Companies, is all in to provide a healthier future to its customers. With the increase in customers’ trend of buying wellness products in recent years, Albertsons Companies is trying to grab onto the opportunity of outshining other retailers by focusing on offering ‘food as medicine’ programmes. The firm has collaborated with healthcare technology companies, technological payment platforms, and healthy food programmes to map out a proper channel through which customers can get fresh produce and medication. Read More from GroceryDive

Sidekick to invest $55 in digital therapeutics programmes to treat chronic illnesses

HealthGeniuses May 9, 2022

Digital therapeutics developer, Sidekick Health, has recently collaborated with the health insurance behemoth Anthem with the intention of extending their gaming platform to treat patients suffering from chronic diseases. The software devised by Sidekick will assist the patients in tracking their symptoms, managing sleep patterns, nutrition and stress while providing recommendations accordingly. Due to this software, communication between healthcare providers and patients will be rendered effective. The Swedish firm has collected a revenue of $55 million to build and reinforce therapeutics in the U.S. After forming partnerships with firms like Big Pharma, Sidekick is currently working with Anthem to offer caretaking services to individuals suffering from Crohn’s disease and COVID-19. The objective of Sidekick is to encompass 40 therapeutical areas. Read More from Fierce

Orion joins hands with Jemincare to formulate non-opioid drug for chronic pain

HealthGeniuses May 9, 2022

Jemincare, with the help of Orion, will be furthering the development of their non-opioid drug JMKX000623, an inhibitor of a main sodium channel subtype that balances out pain fibres’ stimulation. Orion corporation has partnered up with Jemincare where the former will be responsible for the international development and marketing rights of the non-opioid drug. This drug will treat acute as well as chronic pain. In addition to royalty payments, Orion will also make an upfront payment of $15 million to Jemincare. Read More from Pharmaceutical Technology 

Albertsons Companies is focusing on the concept of ‘food as medicine’ for shoppers

HealthGeniuses May 9, 2022

One of the leading food and medicine retailers, Albertsons Companies, is all in to provide a healthier future to its customers. With the increase in customers’ trend of buying wellness products in recent years, Albertsons Companies is trying to grab onto the opportunity of outshining other retailers by focusing on offering ‘food as medicine’ programmes. The firm has collaborated with healthcare technology companies, technological payment platforms, and healthy food programmes to map out a proper channel through which customers can get fresh produce and medication. Read More from GroceryDive

Sidekick to invest $55 in digital therapeutics programmes to treat chronic illnesses

HealthGeniuses May 9, 2022

Digital therapeutics developer, Sidekick Health, has recently collaborated with the health insurance behemoth Anthem with the intention of extending their gaming platform to treat patients suffering from chronic diseases. The software devised by Sidekick will assist the patients in tracking their symptoms, managing sleep patterns, nutrition and stress while providing recommendations accordingly. Due to this software, communication between healthcare providers and patients will be rendered effective. The Swedish firm has collected a revenue of $55 million to build and reinforce therapeutics in the U.S. After forming partnerships with firms like Big Pharma, Sidekick is currently working with Anthem to offer caretaking services to individuals suffering from Crohn’s disease and COVID-19. The objective of Sidekick is to encompass 40 therapeutical areas. Read More from Fierce

HealthGeniuses

Curated News and Digital
Insights for the Healthcare Industry

IndustryGeniuses
GroceryGeniuses
ConsumerGeniuses
MetaGeniuses
FashionGeniuses

HealthGeniuses

According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.

Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.

HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.

IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.

© 2024 IndustryGeniuses Ltd. All Rights Reserved.